Methysergide as the cause to toxic psychoses
Major, P.
Tidsskrift for den Norske Laegeforening Tidsskrift for Praktisk Medicin Ny Raekke 103(28): 1940-1942
1983
ISSN/ISBN: 0029-2001 PMID: 6648934 Document Number: 214568
Document emailed within 1 workday
Related Documents
Aripov, U.A.; Avakov, V.E.; Nisimov, P.B. 1979: Metabolic disorders in patients with postoperative toxic psychoses Anesteziologiia i Reanimatologiia 3: 55-58Vaindrukh, F.A.; Nazarov, K.N. 1973: Constitution and psychoses (body build and psychoses) (review of the literature) Zhurnal Nevropatologii i Psikhiatrii Imeni S.S. Korsakova 73(1): 140-148
Goudemand, M.; Goudemand, J.; Goudemand-Joubert, C.; Parquet, P.J. 1981: Heredity and childhood psychoses : histocompatibility antigens (HLA a and B) and early onset childhood psychoses Acta Psychiatrica Belgica 81(1): 57-71
Bredberg, U.; Paalzow, L. 1990: Pharmacokinetics of methysergide and its metabolite methylergometrine in the rat Drug Metabolism and Disposition: the Biological Fate of Chemicals 18(3): 338-343
Wagenknecht, L.V. 1972: Retroperitoneal fibrosis following methysergide therapy Münchener Medizinische Wochenschrift 114(13): 585-588
Akoun, G.; Herson, S.; Huchon, G.; Marsac, J. 1976: Pleuro-pulmonary fibrosis caused by methysergide Semaine des Hopitaux. Therapeutique 52(1): 9-13
Salner, A.L.; Mullany, L.D.; Cole, S.R. 1980: Methysergide induced mitral valvular insufficiency Connecticut Medicine 44(1): 6-8
Sofia, R.D.; Vassar, H.B. 1975: The effect of ergotamine and methysergide on serotonin metabolism in the rat brain Archives Internationales de Pharmacodynamie et de Therapie 216(1): 40-50
Poisot, D.; Choussat, A.; Baudet, E.; Doutres, J.C.; Lange, D.; Aparicio, M.; Dallocchio, M.; Martin-Dupont, C.; Bricaud, H. 1972: Retroperitoneal fibrosis due to methysergide with compression of the ureters and iliac arteries (apropos of a case) Bordeaux Medical 5(6): 651-659
Ratner, A.; Woo, W.; Yelvington, D.; Torres, K. 1981: Effect of lergotrile mesylate and methysergide on morphine induced increase in prolactin release Proceedings of the Western Pharmacology Society 24: 335-339
Czajkowska, T.; Krysiak, B. 1987: Experimental studies of the toxic effects of 1,3,5-trioxane and 1,3-dioxolane. II. Cumulation of toxic effect Medycyna Pracy 38(4): 244-249
Czajkowska, T.; Krysiak, B.; Popińska, E. 1987: Experimental studies of toxic effects of 1,3,5-trioxane and 1,3-dioxolane. I. Acute toxic effect Medycyna Pracy 38(3): 184-190
Engelbrecht, F.M.; de Klerk, G. 1972: The oxygen uptake of alveolar and peritoneal macrophages during phagocytosis of toxic and non-toxic dust particles South African Medical Journal 46(46): 1791-1794
Ruszczak, Z.; Onisk, Z.; Wyszogrodzka, M. 1971: The so-called toxic epidermolysis (Lyell's toxic epidermal necrolysis) Przeglad Dermatologiczny 58(4): 449-454
Borowiak, K. 1995: Activity of choline esterases in blood cells and serum and cobalt activated acylase in toxic and non-toxic liver damage Annales Academiae Medicae Stetinensis 41: 145-154
Pontiroli, A.E.; Castegnaro, E.; Vettaro, M.P.; Viberti, G.C.; Pozza, G. 1977: Stimulatory effect of the dopa-decarboxylase inhibitor Ro 4-4602 on prolactin release; inhibition by l-dopa, metergoline, methysergide and 2-Br-alpha-ergocryptine Acta Endocrinologica 84(1): 36-44
Derwahl, M. 1999: Mutations in the thyrotropin receptor gene in the pathogenesis of toxic thyroid adenomas, toxic goiter nodules and autosomal dominant hyperthyroidism Zeitschrift für Arztliche Fortbildung und Qualitatssicherung 93(Suppl 1): 25-28
Katsuta, H.; Takaoka, T.; Nagai, Y.; Hoshi, M. 1974: Toxic metabolites released from rat hepatoma cells in culture. 2. Biological and chemical analyses of toxic metabolites Japanese Journal of Experimental Medicine 44(1): 97-113
Tierno, P.M.; Hanna, B.A. 1989: Ecology of toxic shock syndrome: amplification of toxic shock syndrome toxin 1 by materials of medical interest Reviews of Infectious Diseases 11(Suppl 1): S182
Pejchl, J. 1989: Symptomatic psychoses Ceskoslovenska Psychiatrie 85(2): 127-137